tiprankstipranks
Trending News
More News >
InnoCare Pharma Ltd. (HK:9969)
:9969
Hong Kong Market

InnoCare Pharma Ltd. (9969) Financial Statements

Compare
2 Followers

InnoCare Pharma Ltd. Financial Overview

InnoCare Pharma Ltd.'s market cap is currently HK$17.44B. The company's EPS TTM is HK$-0.0224734504; its P/E ratio is -82.29; InnoCare Pharma Ltd. is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is HK$0.36. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 1.01B¥ 738.54M¥ 625.40M¥ 1.04B¥ 1.36M
Gross Profit¥ 871.01M¥ 610.10M¥ 482.01M¥ 977.37M¥ 1.36M
Operating Income¥ -525.78M¥ -651.15M¥ -770.40M¥ -181.10M¥ -558.99M
EBITDA¥ -463.49M¥ -516.55M¥ -808.28M¥ 16.23M¥ -556.92M
Net Income¥ -440.63M¥ -631.26M¥ -886.59M¥ -64.55M¥ -391.39M
Balance Sheet
Cash & Short-Term Investments¥ 6.22B¥ 8.22B¥ 9.01B¥ 6.25B¥ 3.97B
Total Assets¥ 9.41B¥ 9.92B¥ 10.32B¥ 7.40B¥ 4.54B
Total Debt¥ 1.27B¥ 1.35B¥ 1.25B¥ 1.27B¥ 1.17B
Net Debt¥ -4.95B¥ -6.88B¥ -7.45B¥ -4.66B¥ -2.80B
Total Liabilities¥ 2.66B¥ 2.74B¥ 2.68B¥ 1.74B¥ 1.38B
Stockholders' Equity¥ 6.73B¥ 7.15B¥ 7.60B¥ 5.60B¥ 3.10B
Cash Flow
Free Cash Flow¥ -443.78M¥ -926.00M¥ -935.88M¥ -11.00K¥ -423.79M
Operating Cash Flow¥ -365.55M¥ -671.34M¥ -565.55M¥ 167.06M¥ -172.52M
Investing Cash Flow¥ 1.11B¥ 666.91M¥ -1.73B¥ -1.73B¥ -1.11B
Financing Cash Flow¥ -285.60M¥ 1.31M¥ 3.09B¥ 2.54B¥ 2.24B
Currency in CNY

InnoCare Pharma Ltd. Earnings and Revenue History

InnoCare Pharma Ltd. Debt to Assets

InnoCare Pharma Ltd. Cash Flow

InnoCare Pharma Ltd. Forecast EPS vs Actual EPS